Author:
Ghetie Maria-Ana,Crank Michelle,Kufert Stephanie,Pop Iliodora,Vitetta Ellen
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology,Immunology,Immunology and Allergy
Reference40 articles.
1. Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma;Grillo-Lopez;Semin Oncol,1999
2. Clinical applications of anti-CD20 antibodies;Gopal;J Lab Clin Med,1999
3. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J Clin Oncol,1998
4. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy;Czuczman;J Clin Oncol,1999
5. Rituximab: converging mechanisms of action in non-Hodgkin's Lymphoma?;Eisenbeis;Clin Cancer Res,2003
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献